Avaii Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$729K Sell
793
-21
-3% -$21.3K 0.25% 52
2025
Q4
$875K Buy
814
+6
+0.7% +$5.74K 0.32% 39
2025
Q3
$617K Buy
808
+6
+0.7% +$4.46K 0.23% 57
2025
Q2
$625K Buy
802
+1
+0.1% +$777 0.28% 49
2025
Q1
$662K Buy
801
+13
+2% +$10.8K 0.35% 39
2024
Q4
$609K Sell
788
-31
-4% -$25.7K 0.3% 49
2024
Q3
$726K Sell
819
-122
-13% -$110K 0.37% 39
2024
Q2
$852K Sell
941
-9
-0.9% -$7.2K 0.47% 41
2024
Q1
$739K Buy
950
+13
+1% +$9.25K 0.43% 42
2023
Q4
$546K Buy
937
+8
+0.9% +$4.67K 0.36% 62
2023
Q3
$499K Sell
929
-9
-1% -$4.64K 0.38% 59
2023
Q2
$440K Buy
938
+55
+6% +$23.1K 0.34% 69
2023
Q1
$303K Sell
883
-7
-0.8% -$2.36K 0.26% 91
2022
Q4
$325K Buy
890
+14
+2% +$4.96K 0.29% 85
2022
Q3
$283K Buy
876
+26
+3% +$8.24K 0.29% 81
2022
Q2
$275K Buy
850
+66
+8% +$19.8K 0.29% 73
2022
Q1
$224K Buy
+784
New +$202K 0.21% 96

Other funds holding LLY

Avaii Wealth Management's LLY Position: Q1 2026 in Review

Avaii Wealth Management reduced its Eli Lilly (LLY) stake by 2.6% in Q1 2026, selling an estimated $21.3K and leaving 793 shares worth $729K. The position accounts for 0.25% of the portfolio, ranked #52.

Avaii Wealth Management first reported a position in LLY in Q1 2022 and has held it in 17 quarters since. The position peaked at $875K in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Avaii Wealth Management held 793 shares of Eli Lilly worth $729K as of Q1 2026.
  • Avaii Wealth Management sold 21 Eli Lilly shares in Q1 2026, an estimated $21.3K.
  • Eli Lilly made up 0.25% of Avaii Wealth Management's portfolio in Q1 2026, its #52 holding.
  • Avaii Wealth Management first reported a position in Eli Lilly in Q1 2022 and has held it in 17 quarters since.
  • Avaii Wealth Management's Eli Lilly position peaked at $875K in Q4 2025.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Avaii Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.